Vagus nerve stimulation reduces body weight and fat mass in rats

• Published in: PloS one 2012-09, Vol.7 (9), p.e44813-e44813
• Main Authors: Banni, Sebastiano, Carta, Gianfranca, Murru, Elisabetta, Cordeddu, Lina, Giordano, Elena, Marrosu, Francesco, Puligheddu, Monica, Floris, Gabriele, Asuni, Gino Paolo, Cappai, Angela Letizia, Deriu, Silvia, Follesa, Paolo
• Format: Article
• Language: English
• Subjects: Adipose tissue; Adipose Tissue - metabolism; Animal experimentation; Animal Feed; Animals; Biology; Body fat; Body Weight; Body weight gain; Brain; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Cannabinoids; Care and treatment; Conversion; Diet; Dietary intake; Down-regulation; Drug delivery systems; Drug resistance; Endocannabinoids - metabolism; Energy; Energy expenditure; Environmental science; Epilepsy; Esterification; Fatty acids; Fatty Acids, Nonesterified - metabolism; Feed conversion; Food; Gene expression; Gene Expression Regulation; Health aspects; Hypothalamus; Hypothalamus - metabolism; Kinases; Ligands; Liver; Liver - metabolism; Male; Medicine; Metabolism; Multiple sclerosis; Nervous system; Neurobiology; Neurosciences; Oxidation; Palmitoylethanolamide; PPAR alpha - metabolism; Public health; Rats; Rats, Sprague-Dawley; Rodents; Stimulation; Time Factors; Vagus nerve; Vagus nerve stimulation; Vagus Nerve Stimulation - adverse effects; Weight control; Weight reduction
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0044813

Among the manifold effects of vagus nerve stimulation (VNS) delivered as an add-on treatment to patients with drug-resistant epilepsy, a moderate loss of body weight has been observed in some individuals. We have now investigated this effect in rats. Exposure of rats to VNS for 4 weeks reduced feed conversion efficiency as well as body weight gain (by ∼25%) and the amount of mesenteric adipose tissue (by ∼45%) in comparison with those in sham-operated control animals. A pair-fed experiment showed that both lower dietary intake and increase energy expenditure independently contributed to the reduction of body weight and mesenteric adipose tissue. Moreover, VNS increased the level of non-esterified fatty acids in plasma and mesenteric adipose tissue by ∼50 and 80%, respectively, without affecting that in the liver. In addition, VNS reduced the amounts of endocannabinoids and increased N-palmitoylethanolamide, an endogenous ligand of the transcription factor PPARα (peroxisome proliferator-activated receptor α) in mesenteric adipose tissue but not in the hypothalamus. These effects were accompanied by increased expression of the gene for brain-derived neurotrophic factor (BDNF) in the hypothalamus and up-regulation of the abundance of PPARα in the liver. Our results suggest that the reduction in body fat induced by VNS in rats may result from the action of both central and peripheral mediators. The reduced feed conversion efficiency associated with VNS may be mediated by hypothalamic BDNF, down-regulation of endocannabinoid tone in mesenteric adipose tissue and a PPARα-dependent increase in fatty acid oxidation in the liver, which in concerted action may account for the anorexic effect and increased energy expenditure.